| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,422,531 |
|
|
|
Indirect Value
|
$12,587,781 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$46,010,312 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -761.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
13,420,970 |
13,420,970 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2022-07-28 |
4 |
A |
$4.61 |
$15,000,000 |
I/I |
3,253,796 |
16,674,766 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
157,500 |
1,187,738 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
1,038,224 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
58,800 |
865,407 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-07-12 |
4 |
AS |
$120.00 |
$6,000,000 |
D/D |
(50,000) |
312,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-07-12 |
4 |
OE |
$11.92 |
$667,648 |
D/D |
50,000 |
362,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-10-28 |
4 |
OE |
$17.65 |
$882,500 |
D/D |
50,000 |
360,808 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-10-28 |
4 |
AS |
$122.80 |
$6,148,255 |
D/D |
(50,000) |
310,808 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-03 |
4 |
AS |
$195.55 |
$9,918,230 |
D/D |
(50,000) |
162,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-03 |
4 |
OE |
$17.98 |
$957,400 |
D/D |
50,000 |
212,770 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
48,838 |
907,795 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-04-26 |
4 |
AS |
$89.90 |
$4,318,907 |
D/D |
(48,000) |
315,388 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-12-18 |
4 |
AS |
$127.81 |
$4,093,243 |
D/D |
(32,026) |
134,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-12-18 |
4 |
OE |
$17.65 |
$565,259 |
D/D |
32,026 |
166,347 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-27 |
4 |
S |
$106.14 |
$3,361,363 |
D/D |
(30,868) |
314,520 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
AS |
$50.01 |
$1,500,300 |
D/D |
(30,000) |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
OE |
$13.79 |
$413,700 |
D/D |
30,000 |
84,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-27 |
4 |
OE |
$11.92 |
$357,600 |
D/D |
30,000 |
345,388 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-11-03 |
4 |
OE |
$17.96 |
$538,800 |
D/D |
30,000 |
192,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-11-03 |
4 |
AS |
$190.56 |
$5,729,619 |
D/D |
(30,000) |
162,770 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,400 |
939,656 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,974 |
134,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-01-09 |
4 |
OE |
$5.18 |
$203,570 |
D/D |
25,664 |
377,767 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-25 |
4 |
AS |
$58.27 |
$1,484,514 |
D/D |
(25,434) |
352,974 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
